文献速递肝病

大肠杆菌与人原发性胆汁性胆管炎的病因学:抗线粒体抗体与决定簇扩散

E. coli and the etiology of human PBC: Antimitochondrial antibodies and spreading determinants.
PubMed 文献 · Hepatology · 2021-12-12

该研究通过构建人及大肠杆菌PDC-E2特异构件,评估自身抗体反应特异性,探讨大肠杆菌暴露是否为基础导致抗线粒体抗体(AMA)应答。结果显示,针对人PDC-E2脂酰结构域(hPDC-E2LD)的亲和纯化抗体仅能被hPDC-E2LD吸收去除,而不能被ePDC-E2去除,提示存在独特的人PDC-E2表位;单独重组ePDC-E2的LD1、LD2、LD3不与AMA或抗硫辛酸(anti-LA)反应,但串联表达的LD1-LD2-LD3(LP)可被anti-LA识别,且与硫辛酸预培养后反应增强;串联表达或不同质粒表达时LD领域被脂酰化并可被PBC血清识别。结论认为,大肠杆菌暴露引发针对ePDC-E2的特异性抗体,导致决定簇扩散和经典抗hPDC-E2LD自身抗体产生,可能是人PBC发生的第一步。

要点

  • 抗hPDC-E2LD抗体仅被hPDC-E2LD吸收去除,不被ePDC-E2去除,提示人PDC-E2存在独特表位。
  • 单独重组ePDC-E2的LD1、LD2、LD3不与AMA或anti-LA反应,串联表达(LP)后可被anti-LA识别。
  • LP与硫辛酸预培养后anti-LA反应增强;LD领域脂酰化后可被PBC血清识别。

核心结论

  • 大肠杆菌暴露引发针对ePDC-E2的特异性抗体,导致决定簇扩散和经典抗hPDC-E2LD自身抗体产生,可能是人PBC发生的第一步。

研究设计与样本

  • 基础研究,通过生成人和大肠杆菌PDC-E2的特异构件,评估自身抗体反应特异性及硫辛酸对ePDC-E2构象和AMA识别的影响。

主要发现

  • 抗hPDC-E2LD亲和纯化抗体仅被hPDC-E2LD吸收去除,不被ePDC-E2去除,提示存在独特的人PDC-E2表位。
  • 单独重组ePDC-E2的LD1、LD2、LD3不与AMA或anti-LA反应,但串联表达的LP可被anti-LA识别。
  • LP与硫辛酸预培养后anti-LA反应增强;LD1、LD2、LD3串联表达于pET28a或LD1表达于pGEX时被脂酰化并可被PBC血清识别。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: The increased frequency of urinary tract infections in patients with primary biliary cholangitis (PBC) and the cross-reactivity between the lipoyl domains (LD) of human pyruvate dehydrogenase complex (hPDC-E2) and Escherichia coli PDC-E2 (ePDC-E2) have long suggested a role of E. coli in causality of PBC. This issue, however, has remained speculative. We hypothesized that by generating specific constructs of human and E. coli PDC-E2, we would be able to assess the specificity of autoantibody responses and define whether exposure to E. coli in susceptible hosts is the basis for the antimitochondrial antibody (AMA) response. APPROACH AND RESULTS: Importantly, the reactivity of hPDC-E2 LD (hPDC-E2LD) affinity-purified antibodies against hPDC-E2LD could only be removed by prior absorption with hPDC-E2LD and not ePDC-E2, suggesting the presence of unique human PDC-E2 epitopes distinct from E. coli PDC-E2. To identify the autoepitope(s) present in hPDC-E2LD, a more detailed study using a variety of PDC-E2 constructs was tested, including the effect of lipoic acid (LA) on ePDC-E2 conformation and AMA recognition. Individual recombinant ePDCE2 LD domains LD1, LD2 and LD3 did not react with either AMA or antibodies to LA (anti-LA), but in contrast, anti-LA was readily reactive against purified recombinant LD1, LD2, and LD3 expressed in tandem (LP); such reactivity increased when LP was precultured with LA. Moreover, when the three LD (LD1, LD2, LD3) domains were expressed in tandem in pET28a or when LD1 was expressed in another plasmid pGEX, they were lipoylated and reactive to PBC sera. CONCLUSIONS: In conclusion, our data are consistent with an exposure to E. coli that elicits specific antibody to ePDC-E2 resulting in determinant spreading and the classic autoantibody to hPDC-E2LD. We argue this is the first step to development of human PBC.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Yang Y, Choi J, Chen Y, et al. E. coli and the etiology of human PBC: Antimitochondrial antibodies and spreading determinants. Hepatology. 2021. PMID: 34608663. doi:10.1002/hep.32172

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。